Study 5 of 38 for search of: "Enterocolitis"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Necrotizing Enterocolitis (NEC) Surgical Database
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Children's Hospital Boston
Glaser Pediatric Research Network
Elizabeth Glaser Pediatric AIDS Foundation
Yale University
Information provided by: Children's Hospital Boston
ClinicalTrials.gov Identifier: NCT00120159
  Purpose

The general objectives of this protocol are to develop a multi-center prospective data collection process to identify risk factors for progression of Necrotizing Enterocolitis (NEC). These data will be used as a basis for identifying management strategies appropriate for further evaluation (randomized controlled trials), to develop evidence-based standards of care, and as a tool to facilitate quality-assessment at individual centers through comparison of outcomes with the entire database.


Condition
Necrotizing Enterocolitis

U.S. FDA Resources
Study Type: Observational
Study Design: Retrospective
Official Title: GPRN Neonatal Surgical Database: Necrotizing Enterocolitis (NEC) Protocol

Further study details as provided by Children's Hospital Boston:

Estimated Enrollment: 300
Study Start Date: December 2003
  Eligibility

Ages Eligible for Study:   up to 2 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Patients must meet at least one criterion from each of the following three categories:

Historical Factors:

  • Feeding intolerance defined as vomiting of 2 or more feedings within 24 hours or any vomitus containing bile, or the presence of gastric residuals of volume greater than 6cc/kg or any aspirate containing bile
  • Apneic/bradycardic episodes
  • Oxygen desaturation episode not otherwise explained
  • Guaiac positive or grossly bloody stools

Physical Examination Findings:

  • Abdominal distention recorded by practitioner
  • Capillary refill time greater than 2 seconds
  • Abdominal wall discoloration
  • Abdominal tenderness

Radiographic Findings:

  • Pneumatosis intestinalis
  • Portal venous gas
  • Ileus
  • Dilated bowel
  • Pneumoperitoneum
  • Air/fluid levels
  • Thickened bowel walls
  • Ascites or peritoneal fluid
  • Free intraperitoneal air

Exclusion Criteria:

Patients will be excluded for any of the following:

  • Major gastrointestinal anomaly
  • Prior abdominal operation
  • Family does not consent to participate (A list of patients for whom consent was refused will be maintained in order to avoid contacting these families repeatedly. All families who refuse consent will be queried as to the reason for refusal).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00120159

Locations
United States, Massachusetts
Children's Hospital, Boston
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Children's Hospital Boston
Glaser Pediatric Research Network
Elizabeth Glaser Pediatric AIDS Foundation
Yale University
Investigators
Principal Investigator: Tom Jaskic, MPH, PhD Children's Hospital Boston
  More Information

Study ID Numbers: X03-12-080
Study First Received: June 30, 2005
Last Updated: January 14, 2008
ClinicalTrials.gov Identifier: NCT00120159  
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
Necrotizing Enterocolitis

Study placed in the following topic categories:
Digestive System Diseases
Gastrointestinal Diseases
Necrotizing enterocolitis
Intestinal Diseases
Gastroenteritis
Enterocolitis, Necrotizing
Enterocolitis

ClinicalTrials.gov processed this record on January 16, 2009